NCT04306900 2025-07-29TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersTrishula Therapeutics, Inc.Phase 1 Completed185 enrolled 28 charts
NCT04165031 2021-11-24A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C MutationEli Lilly and CompanyPhase 1/2 Terminated5 enrolled 9 charts